BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with tha...

November 27, 2023 | News

DxVx Plans License-In of OVM-200, Launches Clinical Trials in Asia

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK- DxVx plans to proceed its own clinical trials in Asia, including Korea and Chi...

November 27, 2023 | News

PharmAbcine Reveals PMC-403 Potential in Idiopathic Systemic Capillary Leak Syndrome Models

The results underscore the novel mechanism of action, demonstrating the ability of PMC-403 to reduce vascular leakage associated with ISCLS in the preclini...

November 23, 2023 | News

SK Bioscience and Hilleman Labs Collaborate on Next-Gen Ebola Vaccine

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entere...

November 22, 2023 | News

Lunit's AI Chest Screening to Deploy in Five Saudi Hospitals

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced an expansion of its services in the&nb...

November 17, 2023 | News

South Korean Firm Lunit Raises $150 Million in Capital Boost

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the successful completion ...

November 16, 2023 | News

Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market

Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has received U.S. Food and Dr...

November 15, 2023 | News

Guardant Health Introduces Shield Blood Test for Colorectal Cancer in South Korea

Colorectal cancer (CRC) is one of the most commonly diagnosed cancers and the third-leading cause of cancer-related deaths in South Korea.1,2 Gua...

November 13, 2023 | News

PharmAbcine Advances PMC-403 Clinical Trial in South Korea for Macular Degeneration

Safety Review Committee evaluated dose level 1 safety data of PMC-403 and approved advancing to the higher dose treatment. The starting dose (0.7m...

November 10, 2023 | News

GC Biopharma Seeks South Korean MFDS Approval for World's First Recombinant Anthrax Vaccine.

'GC1109' contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of protein...

November 06, 2023 | News

Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T

Anbal-cel argeting DLBCL completes phase 2 trial Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review Commerci...

November 02, 2023 | News

Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced a research collaboration with The ...

October 30, 2023 | News

Samsung Biologics and Kurma Partners Forge Biologics Development & Manufacturing Alliance for Kurma's Portfolio

- Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of developmen...

October 25, 2023 | News

VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain®

VUNO Med®-DeepBrain® is intended to automate the current manual process of identifying, labeling, and quantifying segmentable brain structures from...

October 24, 2023 | News

Stay Connected